Global Cord Blood Corporation, announced that in response to the non-binding proposal letter dated June 4, 2019 received by the Company’s Board of Directors from Cordlife Group Limited pursuant to which Cordlife proposes to combine the businesses of Cordlife and the Company by way of a statutory merger, the Board has formed a special committee of independent directors who are not affiliated with Cordlife to evaluate such proposal.
June 6, 2019
· 3 min read